Spartan Planning & Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$666K Buy
5,533
+750
+16% +$86.6K 0.49% 32
2025
Q4
$503K Buy
+4,783
New +$449K 0.37% 40
2023
Q4
$235K Sell
2,158
-149
-6% -$15.5K 0.25% 50
2023
Q3
$238K Buy
+2,307
New +$249K 0.28% 53
2022
Q4
$402K Buy
3,619
+1,004
+38% +$103K 0.5% 31
2022
Q3
$225K Sell
2,615
-1,411
-35% -$126K 0.29% 22
2022
Q2
$367K Buy
4,026
+4,023
+134,100% +$357K 0.49% 23
2022
Q1
$0 Buy
+3
New +$237 ﹤0.01% 139

Other funds holding MRK

Spartan Planning & Wealth Management's MRK Position: Q1 2026 in Review

Spartan Planning & Wealth Management increased its Merck (MRK) stake by 16% in Q1 2026, buying an estimated $86.6K and bringing the position to 5,533 shares worth $666K. The position accounts for 0.49% of the portfolio, ranked #32.

Spartan Planning & Wealth Management first reported a position in MRK in Q1 2022 and has held it in 8 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Spartan Planning & Wealth Management held 5,533 shares of Merck worth $666K as of Q1 2026.
  • Spartan Planning & Wealth Management bought 750 Merck shares in Q1 2026, an estimated $86.6K.
  • Merck made up 0.49% of Spartan Planning & Wealth Management's portfolio in Q1 2026, its #32 holding.
  • Spartan Planning & Wealth Management first reported a position in Merck in Q1 2022 and has held it in 8 quarters since.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Spartan Planning & Wealth Management's 13F filing for Q1 2026, filed 16 Apr 2026.